Dashboard
Manage Tickers

DTILPRECISION BIOSCIENCES INC

Nasdaq precisionbiosciences.com


$ 9.79 $ 0.31 (3.29 %)    

Friday, 28-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 9.73
$ 9.56
$ 9.46 x 100
$ 0.00 x 0
$ 9.35 - $ 9.79
$ 8.25 - $ 21.90
86,479
na
49.27M
$ 1.73
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-10-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 04-29-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

precision-biosciences-showcases-arcus-platform-at-mitochondrial-medicine-2024
Precision BioSciences Showcases ARCUS Plat...
06/27/2024 11:07:57

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

precision-biosciences-to-present-preclinical-data-on-hepatitis-b-treatment-at-easl-congress
Precision BioSciences to Present Preclinic...
06/05/2024 11:07:19

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
05/30/2024 11:09:37

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

deep-dive-into-precision-biosciences-stock-analyst-perspectives-4-ratings
Deep Dive Into Precision BioSciences Stock...
05/16/2024 18:00:24

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
05/16/2024 17:36:26

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

precision-biosciences-q1-eps-170-beats-191-estimate-sales-1758m-beat-602m-estimate
Precision BioSciences Q1 EPS $1.70 Beats $...
05/13/2024 11:03:30

Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of...

precision-biosciences-announces-common-stock-purchase-by-members-of-management-including-ceo--for-300000-in-private-placement
Precision BioSciences Announces Common Sto...
05/08/2024 12:18:51

precision-biosciences-announces-receipt-of-fda-fast-track-designation-for-ecur-506-iecures-program-for-the-treatment-of-neonatal-onset-ornithine-transcarbamylase-deficiency
Precision BioSciences Announces Receipt Of...
05/07/2024 12:37:53

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

precision-biosciences-disclosed-late-breaking-poster-presentation-at-the-european-association-for-study-of-the-liver-congress-2024
Precision Biosciences Disclosed Late-break...
05/01/2024 11:27:47

guggenheim-initiates-coverage-on-precision-biosciences-with-buy-rating-announces-price-target-of-19
Guggenheim Initiates Coverage On Precision...
04/30/2024 11:41:44

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and anno...

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
04/17/2024 17:26:55

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 12:08:12

precision-biosciences-announces-return-of-programs-and-conclusion-of-collaboration-with-prevail-therapeutics
Precision BioSciences Announces Return Of ...
04/16/2024 20:17:19

- Productive collaboration advanced three programs and demonstrated proof of concept of ARCUS for gene excision and gene insert...

iecure-announces-fda-clearance-of-ind-application-for-ecur-506-to-initiate-otc-hope-trial-for-treatment-of-neonatal-onset-ornithine-transcarbamylase-deficiency-in-the-us-note-iecure-has-licensed-the-arcus-nuclease-for-ecur-506-from-precision-biosciences
iECURE Announces FDA Clearance Of IND Appl...
04/04/2024 15:02:53

Clinical trial sites in the United States, United Kingdom, and Australia will evaluate ECUR-506, an investigational gene editin...

hc-wainwright--co-maintains-buy-on-precision-biosciences-adjusts-price-target-to-60
HC Wainwright & Co. Maintains Buy on Preci...
03/28/2024 14:56:08

HC Wainwright & Co. analyst Patrick Trucchio maintains Precision BioSciences (NASDAQ:DTIL) with a Buy, adjusts target to...

precision-biosciences-2023-cash-and-cash-equivalents-of-1167m-cash-received-from-tg-therapeutics-caribou-of-50m-and-40m-capital-raise-is-expected-to-provide-cash-runway-into-2h-of-2026
Precision Biosciences' 2023 Cash And Cash ...
03/27/2024 10:58:57

precision-biosciences-q4-gaap-eps-406-may-not-be-comparable-to-205-estimate-sales-704m-miss-1248m-estimate
Precision BioSciences Q4 GAAP EPS $(4.06) ...
03/27/2024 10:48:11

Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(4.06) per share which missed the analyst consensus estimate ...

earnings-scheduled-for-march-27-2024
Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

earnings-preview-precision-biosciences
Earnings Preview: Precision BioSciences
03/26/2024 17:00:59

precision-biosciences-announces-mhra-approval-for-partner-iecure-to-expand-phase-12-clinical-trial-of-arcus-gene-editing-program-in-otc-deficiency
Precision BioSciences Announces MHRA Appro...
03/06/2024 13:45:33

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)